CALCULATE YOUR SIP RETURNS

Stocks/Share Market - Angel One

Best Performing Entertainment Stocks in the Last 6 Months

Best Performing Entertainment Stocks in the Last 6 Months

19 July 2024

The entertainment industry in India has been a bustling hub of activity, with several companies achieving remarkable performances in the stock market over the last six months. Here, we will explore the top-performing entertainment stocks, delving into the companies’ backgrounds and the factors contributing to their recent success. Name Current Price (Rs) Market Capitalization (Rs …

Jubilant Pharmova Delivers Strong Q1 FY2025 with Revenue and Profit Growth

Jubilant Pharmova Delivers Strong Q1 FY2025 with Revenue and Profit Growth

19 July 2024

Jubilant Pharmova Limited reported positive results for the first quarter ended June 30, 2024 (Q1 FY2025). Revenue Growth Total income grew by 9% year-over-year (YoY) to Rs. 1,746 crore, driven by: Growth in Ruby-Fill® and new product sales in radiopharmaceuticals. Volume growth in radiopharmacies. Continued momentum in the Allergy Immunotherapy business. Positive performance in CDMO …

Wipro’s Q1 FY2025 Financial Results: Key Highlights and Strategic Insights

Wipro’s Q1 FY2025 Financial Results: Key Highlights and Strategic Insights

19 July 2024

On July 19, 2024, Wipro Limited, a top technology services and consulting firm, shared its financial results for the quarter ending June 30, 2024. Highlights of the Results for the Quarter ended June 30, 2024 Gross revenue stood at ₹219.6 billion ($2,635.8 million), marking a 1.1% decrease from the previous quarter and a 3.8% decline …

Paytm Q1 Results: Net Loss Soars to ₹840 Crore, Revenue Plummets 36%, Stock Up 6%

Paytm Q1 Results: Net Loss Soars to ₹840 Crore, Revenue Plummets 36%, Stock Up 6%

19 July 2024

Paytm, known as One 97 Communications Ltd, recently reported a significant net loss of ₹840 crore for the quarter. This marks a considerable increase from the ₹550 crore loss in the previous quarter and the ₹338 crore loss in the same quarter last year. Despite the widened net loss, Paytm’s share price saw an unexpected …

DP Abhushan Limited Reports Robust Q1FY25 Results with 60% PAT Growth and Strategic Expansion Plans

DP Abhushan Limited Reports Robust Q1FY25 Results with 60% PAT Growth and Strategic Expansion Plans

19 July 2024

On July 18, 2024, DP Abhushan Limited, a renowned jewellery company with an 84-year legacy known for its purity, design standards, transparency, and wide product range, announced its financial results for the first quarter of FY25, ending June 30, 2024. The company operates in eight locations across India. Financial Highlights ₹ In crore Q1FY25 Q4FY24 …

Muthoot Microfin Lowers Interest Rates by 35 bps to Enhance Affordability

Muthoot Microfin Lowers Interest Rates by 35 bps to Enhance Affordability

19 July 2024

Muthoot Microfin Limited has announced a 35 basis points (bps) interest rate cut, the second reduction this year following a 55 bps cut in January. This move lowers the effective lending rate from 23.65% to 23.30%, reflecting the company’s commitment to making financial services more affordable and accessible. Muthoot Microfin has demonstrated significant growth, with …

Zydus Lifesciences Secures USFDA Nod for Diabetes Drug

Zydus Lifesciences Secures USFDA Nod for Diabetes Drug

19 July 2024

About Approval Zydus Lifesciences Limited has achieved a significant milestone with the final approval of its New Drug Application (NDA) by the US Food and Drug Administration (USFDA). This paves the way for Zydus to market ZituvimetTM XR, an extended-release tablet combining sitagliptin and metformin hydrochloride, for the treatment of type 2 diabetes in the …

Caplin Steriles Receives USFDA Nod for Ephedrine Sulfate Injection

Caplin Steriles Receives USFDA Nod for Ephedrine Sulfate Injection

19 July 2024

Caplin Steriles Limited (Caplin), a subsidiary of Caplin Point Laboratories Limited, has secured significant approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ephedrine Sulfate Injection USP, 50 mg/mL Single Dose Vial. This generic version is therapeutically equivalent to the reference-listed drug (RLD) AKOVAZ, manufactured by …

Indian Oil Companies Ramp Up Capital Expenditure in Q1 FY25

Indian Oil Companies Ramp Up Capital Expenditure in Q1 FY25

19 July 2024

India’s state-owned oil companies are accelerating their capital expenditure (capex) plans for the 2024-25 fiscal year. Leading the charge are the Indian Oil Corporation (IOC) and Oil and Natural Gas Corporation (ONGC), which have already spent a significant portion of their annual budgets in the first quarter (Q1). Strong Start to FY25 Indian Oil Corporation …

GPT Infraprojects Secures ₹103 Crore Boost Through Contract Enhancements

GPT Infraprojects Secures ₹103 Crore Boost Through Contract Enhancements

19 July 2024

GPT Infraprojects Limited (GPT), a leading infrastructure construction and engineering company, has secured a significant boost to its order book. The company announced that existing contracts with two prominent clients, the National Highways Authority of India (NHAI) and Eastern Railway, Kolkata, have been enhanced by a combined value of ₹103 crore. This positive development highlights …

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Open Free Demat Account!
Join our 3 Cr+ happy customers